Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation

Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation (HSCT) is an important therapeutic option for some hematological diseases. However, patients who undergo HSCT acquire a state of immunodeficiency that causes significant mortality. Reconstitution of thymic function is needed to support the immune system. One w...

Full description

Bibliographic Details
Main Authors:	Luis Klaus A. da Rocha, Samar Freschi de Barros, Francine Bandeira, Alexia Bollini, Lucia Helena de A. Testa, Anderson João Simione, Marina de O. e Souza, Lilian P. Zanetti, Leila Cibele S. de Oliveira, Ana Claúdia F. dos Santos, Mair Pedro de Souza, Vergílio Antônio R. Colturado, Jorge Kalil, Clarisse M. Machado, Luiza Guilherme
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-09-01
Series:	Frontiers in Immunology
Subjects:	T-cell receptor excision circles T-cell receptor gene autologous hematopoietic stem cell transplantation allogeneic hematopoietic stem cell transplantation malignant hematological diseases immune reconstitution
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2018.01889/full

Similar Items

T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation
by: Pierre Gaudeaux, et al.
Published: (2022-07-01)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
by: Reena V. Jayani, et al.
Published: (2021-03-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Trends in Outcome of Hematopoietic Stem Cell Transplantation: 5000 Transplantations and 30 Years of Single-Center Experience
by: Ludmila Stepanovna Zubarovskaya, et al.
Published: (2023-09-01)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01)

B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children
by: Nicolaas G. van der Maas, et al.
Published: (2019-04-01)

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Nataliya Prokopenko Buxbaum, et al.
Published: (2020-08-01)

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
by: Yue Lu, et al.
Published: (2023-01-01)

Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia
by: Félicité de Charry, et al.
Published: (2023-01-01)

Need for hemodialysis in patients undergoing hematopoietic stem cell transplantation: risk factors and survival in a retrospective cohort
by: Eduardo Cerello Chapchap, et al.
Published: (2023-07-01)

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant
by: Peter Riddell, et al.
Published: (2021-04-01)

ABO Incompatibility and Hematopoietic Stem Cell Transplantation Outcomes
by: Mohammad Vaezi, et al.
Published: (2017-04-01)

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation
by: Ian Pang, et al.
Published: (2022-01-01)

Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
by: Liu Hui, et al.
Published: (2013-02-01)

Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes
by: Taha Al-Juhaishi, et al.
Published: (2022-01-01)

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
by: Lisanne Lutter, et al.
Published: (2018-04-01)

Predicting mortality and cost of hematopoeitic stem-cell transplantation
by: Fábio Rodrigues Kerbauy, et al.
Published: (2012-03-01)

Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial
by: Yu Wang, et al.
Published: (2022-04-01)

Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Mohammad Jahani, et al.
Published: (2011-01-01)

Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Ardeshir Ghavamzadeh, et al.
Published: (2011-03-01)

Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes
by: Sarah Jungius, et al.
Published: (2023-08-01)

Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
by: Wen-Rong Huang, et al.
Published: (2018-01-01)

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn’s Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD—Low Intensity Therapy Evaluation Study Investigators
by: Alan Graham Pockley, et al.
Published: (2018-04-01)

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
by: Gaganvir Parmar, et al.
Published: (2023-03-01)

Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation
by: Zhou Z, et al.
Published: (2023-07-01)

Forty years of haematopoietic stem cell transplantation: a review of the Basel experience
by: Alix Catherine O'Meara, et al.
Published: (2014-02-01)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
by: Jiali Li, et al.
Published: (2020-09-01)

Reações adversas no dia zero do transplante de células-tronco hematopoéticas: revisão integrativa
by: Talita Wérica Borges Figueiredo, et al.
Published: (2018-11-01)

Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients
by: Dominique Farge, et al.
Published: (2017-01-01)

Highly specific functional equivalence of XN-HPC for optimum CD34+ cell count in harvested allogeneic bone marrow stem cell products
by: Aisha Jamal, et al.
Published: (2022-12-01)

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development
by: Dennis Dong Hwan Kim, et al.
Published: (2024-03-01)

Pros and Cons of Cryopreserving Allogeneic Stem Cell Products
by: Caterina Giovanna Valentini, et al.
Published: (2024-03-01)

The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation
by: Shinichiro Morishita, et al.
Published: (2019-01-01)

A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer
by: Nuri Karadurmus, et al.
Published: (2018-04-01)

First Complete Remission versus other- than- First Complete Remission in Acute Myelogenous Leukemia with Allogeneic Hematopoietic Stem Cell Transplantation
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-04-01)

A Comparison of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)

Physiological problems in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation
by: Sevgisun Kapucu, et al.
Published: (2014-01-01)

A Comparison of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia
by: Farnaz Khatami, et al.
Published: (2009-01-01)

First Complete Remission versus other- than- First Complete Remission in Acute Myelogenous Leukemia with Allogeneic Hematopoietic Stem Cell Transplantation
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-06-01)

Russian multicenter clinical trials in acute leukemias
by: E N Parovichnikova, et al.
Published: (2019-07-01)